Fund Overview of Axis Nifty Healthcare Etf-growth
-
₹20.5 CrAUM
-
₹151.35NAV
-
0.34%Expense Ratio
-
EquityFund Category
Returns of Axis Nifty Healthcare Etf-growth
| Tenure | Absolute(%) | Annualised(%) | Category Average(%) |
|---|---|---|---|
| 3 Months | 0.59% | NA | 6.12% |
| 6 Months | 10.40% | NA | 12.92% |
| 1 Year | -1.22% | -1.22% | 6.04% |
| 2 Years | 53.16% | 23.76% | 24.93% |
| 3 Years | 81.07% | 21.89% | 25.71% |
Asset Allocation
equities
99.93%debt instruments
0.19%Axis Nifty Healthcare Etf-growth is one Equity mutual fund offered by Axis Mutual Fund. Launched on 17 May 2021, the fund aims Long term wealth creation solution. The Fund that seeks to track returns by investing in a basket of NIFTY Healthcare Index stocks and aims to achieve returns of the stated index, subject to tracking error. It manages assets worth ₹20.5 crore as on Thu Jul 31, 2025. , with a 52-week NAV range between ₹128.72 and ₹152.97. The expense ratio stands at 0.34%. Fund Manager Manager EducationAbout Axis Nifty Healthcare Etf-growth
The portfolio allocation consists of 99.93% in equities, 0.19% in debt instruments. Managed by Karthik Kumar, it has delivered a return of -1.22% in the last year, a total return since inception of 13.97%.
Key Metrics of Axis Nifty Healthcare Etf-growth
-
Standard Deviation16.51%
-
Sharpe Ratio0.90%
-
Alpha-2.27%
-
Beta1.01%
Fund Details
|
|
Top Performing Mutual Funds
| Fund Names | AUM (Cr) | 1M | 3M | 1Yr | 3Yr | 5Yr |
|---|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | 0.21% | 0.48% | 9.03% | 28.99% | 21.62% |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | 0.12% | 0.25% | 8.10% | 27.87% | 20.55% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | -0.03% | -1.35% | 5.10% | 23.18% | 17.50% |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | -0.13% | -1.67% | 3.76% | 21.53% | 15.83% |
More funds from Axis Mutual Fund
| Fund Names | AUM (Cr) | 1M | 3M | 6M | 1Yr | 3Yr |
|---|
Mutual Fund Calculator
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 29
- 31
- 32
- 33
- 34
- 36
- 37
- 38
- 39
- 40
- 1
- 2
- 3
- 4
- 6
- 7
- 8
- 9
- 11
- 12
- 13
- 14
- 16
- 17
- 18
- 19
- 21
- 22
- 23
- 24
- 26
- 27
- 28
- 30
Top Mutual Funds
| Fund Names | AUM (Cr) | NAV | 3Yr | 5Yr | 10Yr |
|---|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹6,104 | ₹40.45 | 27.87% | 20.55% | - |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹6,104 | ₹43.71 | 28.99% | 21.62% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹872 | ₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹872 | ₹31.21 | 21.53% | 15.83% | - |
| ICICI Prudential Nifty Healthcare Etf - Growth |
₹146 | ₹152.37 | 22.80% | - | - |
| Aditya Birla Sun Life Nifty Healthcare Etf-growth |
₹37 | ₹15.28 | 22.97% | - | - |
Detailed Portfolio
| Stocks | Sector | % of Holding | Value |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd | Healthcare | 18.51% | ₹3.79 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 18.16% | ₹3.67 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 18.16% | ₹3.67 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 17.79% | ₹3.46 Cr |
| Sun Pharmaceutical Industries Ltd | Healthcare | 17.79% | ₹3.46 Cr |
| Max Healthcare Institute Ltd | Healthcare | 9.31% | ₹1.91 Cr |
| Cipla Ltd | Healthcare | 8.80% | ₹1.80 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.72% | ₹1.76 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.72% | ₹1.76 Cr |
| Max Healthcare Institute Ltd | Healthcare | 8.70% | ₹1.76 Cr |
| Max Healthcare Institute Ltd | Healthcare | 8.70% | ₹1.76 Cr |
| Cipla Ltd | Healthcare | 8.95% | ₹1.74 Cr |
| Cipla Ltd | Healthcare | 8.95% | ₹1.74 Cr |
| Cipla Ltd | Healthcare | 8.61% | ₹1.74 Cr |
| Cipla Ltd | Healthcare | 8.61% | ₹1.74 Cr |
| Divi's Laboratories Ltd | Healthcare | 8.42% | ₹1.73 Cr |
| Max Healthcare Institute Ltd | Healthcare | 8.77% | ₹1.71 Cr |
| Max Healthcare Institute Ltd | Healthcare | 8.77% | ₹1.71 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.91% | ₹1.60 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.91% | ₹1.60 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.78% | ₹1.59 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.61% | ₹1.56 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.93% | ₹1.54 Cr |
| Apollo Hospitals Enterprise Ltd | Healthcare | 7.93% | ₹1.54 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.89% | ₹1.54 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.89% | ₹1.54 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.44% | ₹1.50 Cr |
| Dr. Reddy's Laboratories Ltd | Healthcare | 7.44% | ₹1.50 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.65% | ₹1.49 Cr |
| Divi's Laboratories Ltd | Healthcare | 7.65% | ₹1.49 Cr |
| Fortis Healthcare Ltd | Healthcare | 5.43% | ₹1.10 Cr |
| Fortis Healthcare Ltd | Healthcare | 5.43% | ₹1.10 Cr |
| Fortis Healthcare Ltd | Healthcare | 5.35% | ₹1.04 Cr |
| Fortis Healthcare Ltd | Healthcare | 5.35% | ₹1.04 Cr |
| Lupin Ltd | Healthcare | 4.84% | ₹0.98 Cr |
| Lupin Ltd | Healthcare | 4.84% | ₹0.98 Cr |
| Lupin Ltd | Healthcare | 4.69% | ₹0.96 Cr |
| Lupin Ltd | Healthcare | 4.90% | ₹0.95 Cr |
| Lupin Ltd | Healthcare | 4.90% | ₹0.95 Cr |
| Fortis Healthcare Ltd | Healthcare | 4.49% | ₹0.92 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.93% | ₹0.81 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.99% | ₹0.78 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.99% | ₹0.78 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.80% | ₹0.77 Cr |
| Torrent Pharmaceuticals Ltd | Healthcare | 3.80% | ₹0.77 Cr |
| Laurus Labs Ltd | Healthcare | 3.78% | ₹0.76 Cr |
| Laurus Labs Ltd | Healthcare | 3.78% | ₹0.76 Cr |
| Laurus Labs Ltd | Healthcare | 3.44% | ₹0.71 Cr |
| Laurus Labs Ltd | Healthcare | 3.46% | ₹0.67 Cr |
| Laurus Labs Ltd | Healthcare | 3.46% | ₹0.67 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.23% | ₹0.66 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.25% | ₹0.66 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.25% | ₹0.66 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.21% | ₹0.66 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.14% | ₹0.64 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.14% | ₹0.64 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.22% | ₹0.63 Cr |
| Alkem Laboratories Ltd | Healthcare | 3.22% | ₹0.63 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.21% | ₹0.63 Cr |
| Aurobindo Pharma Ltd | Healthcare | 3.21% | ₹0.63 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.12% | ₹0.61 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 3.12% | ₹0.61 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.91% | ₹0.60 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.90% | ₹0.59 Cr |
| Glenmark Pharmaceuticals Ltd | Healthcare | 2.90% | ₹0.59 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.91% | ₹0.57 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.91% | ₹0.57 Cr |
| Alkem Laboratories Ltd | Healthcare | 2.72% | ₹0.56 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.74% | ₹0.55 Cr |
| Mankind Pharma Ltd. | Healthcare | 2.74% | ₹0.55 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.60% | ₹0.51 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.60% | ₹0.51 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.48% | ₹0.50 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.48% | ₹0.50 Cr |
| Zydus Lifesciences Ltd | Healthcare | 2.44% | ₹0.50 Cr |
| Biocon Ltd | Healthcare | 2.37% | ₹0.48 Cr |
| Biocon Ltd | Healthcare | 2.28% | ₹0.46 Cr |
| Biocon Ltd | Healthcare | 2.28% | ₹0.46 Cr |
| Biocon Ltd | Healthcare | 2.17% | ₹0.42 Cr |
| Biocon Ltd | Healthcare | 2.17% | ₹0.42 Cr |
| Ipca Laboratories Ltd | Healthcare | 2.06% | ₹0.42 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.97% | ₹0.38 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.97% | ₹0.38 Cr |
| Abbott India Ltd | Healthcare | 1.80% | ₹0.37 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.80% | ₹0.36 Cr |
| Ipca Laboratories Ltd | Healthcare | 1.80% | ₹0.36 Cr |
| Abbott India Ltd | Healthcare | 1.61% | ₹0.31 Cr |
| Abbott India Ltd | Healthcare | 1.61% | ₹0.31 Cr |
| Abbott India Ltd | Healthcare | 1.53% | ₹0.31 Cr |
| Abbott India Ltd | Healthcare | 1.53% | ₹0.31 Cr |
| Syngene International Ltd | Healthcare | 1.36% | ₹0.28 Cr |
| Syngene International Ltd | Healthcare | 1.26% | ₹0.25 Cr |
| Syngene International Ltd | Healthcare | 1.26% | ₹0.25 Cr |
| Syngene International Ltd | Healthcare | 1.25% | ₹0.24 Cr |
| Syngene International Ltd | Healthcare | 1.25% | ₹0.24 Cr |
| Piramal Pharma Ltd | Healthcare | 1.16% | ₹0.23 Cr |
| Piramal Pharma Ltd | Healthcare | 1.16% | ₹0.23 Cr |
| Piramal Pharma Ltd | Healthcare | 1.15% | ₹0.22 Cr |
| Piramal Pharma Ltd | Healthcare | 1.15% | ₹0.22 Cr |
| Granules India Ltd | Healthcare | 0.69% | ₹0.14 Cr |
| Others Cblo | Unspecified | 0.22% | ₹0.04 Cr |
| Others Cblo | Unspecified | 0.22% | ₹0.04 Cr |
| Others Cblo | Unspecified | 0.19% | ₹0.04 Cr |
| Others Cblo | Unspecified | 0.19% | ₹0.04 Cr |
| Net Receivables | Unspecified | 0.15% | ₹0.03 Cr |
| Others Cblo | Unspecified | 0.09% | ₹0.02 Cr |
| Net Payables | Unspecified | -0.12% | ₹-0.02 Cr |
| Net Payables | Unspecified | -0.12% | ₹-0.02 Cr |
| Net Payables | Unspecified | -0.12% | ₹-0.02 Cr |
| Net Payables | Unspecified | -0.12% | ₹-0.02 Cr |
Top Equity Funds
| Fund Names | NAV | 3Yr | 5Yr | 52 weeks high |
|---|---|---|---|---|
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund Direct - Growth |
₹43.71 | 28.99% | 21.62% | 44.69 |
| ICICI Prudential Pharma Healthcare And Diagnostics (p.h.d) Fund - Growth |
₹40.45 | 27.87% | 20.55% | 41.47 |
| Aditya Birla Sun Life Pharma & Healthcare Fund Direct-growth |
₹34.41 | 23.18% | 17.50% | - |
| Aditya Birla Sun Life Pharma & Healthcare Fund Regular-growth |
₹31.21 | 21.53% | 15.83% | - |
Axis Nifty Healthcare Etf-growth
What is the current AUM of Axis Nifty Healthcare Etf-growth?
As of Thu Jul 31, 2025, Axis Nifty Healthcare Etf-growth manages assets worth ₹20.5 crore
How has Axis Nifty Healthcare Etf-growth performed recently?
- 3 Months: 0.59%
- 6 Months: 10.40%
What is the long-term performance of Axis Nifty Healthcare Etf-growth?
- 3 Years CAGR: 21.89%
- Since Inception: 13.97%
What is the portfolio composition of Axis Nifty Healthcare Etf-growth?
Equity: 99.93%, Debt: 0.19%, Others: -0.12%.
Who manages Axis Nifty Healthcare Etf-growth?
Axis Nifty Healthcare Etf-growth is managed by Karthik Kumar from Axis Mutual Fund.
What is the market-cap allocation of Axis Nifty Healthcare Etf-growth?
Large Cap: 73.44%, Mid Cap: 24.14%, Small Cap: 2.42%.
Which are the top companies Axis Nifty Healthcare Etf-growth has invested in?
- Sun Pharmaceutical Industries Ltd – 18.51% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 18.16% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 18.16% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 17.79% of the fund's portfolio
- Sun Pharmaceutical Industries Ltd – 17.79% of the fund's portfolio
Which are the major sectors Axis Nifty Healthcare Etf-growth focuses on?
- Healthcare – 499.43% of the fund's portfolio
- Unspecified – 0.57% of the fund's portfolio
Policybazaar does not endorse rates/returns or recommend any particular insurer, fund house, AMC (Asset Management Company), insurance and mutual fund product.
Please consult your financial advisor for an informed decision.
Past performance may not be indicative of future results.
The information presented on this page is not owned or generated by Policybazaar. The data has been collected from publicly available sources and online research. We do not claim any ownership or guarantee the accuracy, completeness, or timeliness of this information. It is shared solely for the informational purpose of the viewer and should not be considered as financial advice.
Policybazaar is not acting as a financial advisor, broker, or agent for any mutual fund mentioned here.
Mutual fund investments are subject to market risks. Please read all scheme-related documents carefully before investing.
Policybazaar shall not be held responsible or liable for any losses, damages, or decisions made based on the information provided on this page.
For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product. For a complete list of mutual funds registered in India, please refer to the Securities and Exchange Board of India (SEBI) website at www.sebi.gov.in. We do not sell, endorse, or recommend any mutual fund or investment product.
For more details on risk factors, terms, and conditions, please read the sales brochure and benefit illustration carefully before concluding a sale.
Policybazaar is a registered Insurance Broker | Registration No. 742, Registration Code No. IRDA/ DB 797/ 19, Valid till 09/06/2024, License category- Direct Broker (Life & General) |CIN: U74999HR2014PTC053454 | Registered Office - Plot No.119, Sector - 44, Gurgaon, Haryana – 122001 |Visitors are hereby informed that their information submitted on the website may be shared with insurers. Product information is authentic and solely based on the information received from the insurers.©️ Copyright 2008-2025 policybazaar.com. All Rights Reserved
^Returns as on 10th Jan’25. Tata AIA Life Top 200 ULIP Fund has delivered 18% returns over the last 10 years. Past performance is not necessarily indicative of future results. This disclaimer is specifically regarding a ULIP fund and is not related to mutual funds. Source: Morningstar.


